Objective-To determine whether impairment of endothelial connexin40 (Cx40), an effect that can occur in hypertension and aging, contributes to the arterial dysfunction and stiffening in these conditions. Approach and Results-A new transgenic mouse strain, expressing a mutant Cx40, (Cx40T202S), specifically in the vascular endothelium, has been developed and characterized. This mutation produces nonfunctional hemichannels, whereas gap junctions containing the mutant are electrically, but not chemically, patent. Mesenteric resistance arteries from Cx40T202S mice showed increased sensitivity of the myogenic response to intraluminal pressure in vitro, compared with wildtype mice, whereas transgenic mice overexpressing native Cx40 (Cx40Tg) showed reduced sensitivity. In control and Cx40Tg mice, the sensitivity to pressure of myogenic constriction was modulated by both NO and endothelium-derived hyperpolarization; however, the endothelium-derived hyperpolarization component was absent in Cx40T202S arteries. Analysis of passive mechanical properties revealed that arterial stiffness was enhanced in vessels from Cx40T202S mice, but not in wild-type or Cx40Tg mice. Conclusions-Introduction of a mutant form of Cx40 in the endogenous endothelial Cx40 population prevents endotheliumderived hyperpolarization activation during myogenic constriction, enhancing sensitivity to intraluminal pressure and increasing arterial stiffness. We conclude that genetic polymorphisms in endothelial Cx40 can contribute to the pathogenesis of arterial disease. (Arterioscler Thromb Vasc Biol. 2013;33:962-970.)
S ynchronization of cellular activity through gap junctions, and their constituent connexin (Cx) proteins, is essential for cardiovascular function, both at the level of the heart and the vasculature. 1, 2 During aging and cardiovascular disease, significant changes to Cx expression occur in the vasculature, and these alterations have been linked to the functional deficits found in these conditions. 1, 3 Expression of Cxs37 and 40 is reduced in the endothelium of both muscular and conduit arteries during hypertension, [4] [5] [6] [7] along with gap junctional coupling in the media of muscular arteries 7, 8 ; whereas changes in Cx43 expression in conduit arteries seem to vary among different hypertensive models. 9, 10 Between the 2 vascular cell layers, the incidence of myoendothelial gap junctions is also altered during hypertension, correlating with changes in vasodilation resulting from endothelium-derived hyperpolarization (EDH). 8, 11, 12 Similar changes in gap junction expression also occur during aging; endothelial Cx expression and myoendothelial gap junctions decrease 11, 13, 14 in concert with the functional importance of EDH. 15 What is not clear, however, is whether impairment of arterial gap junctions in ageing and hypertension is causal to, or a consequence of, the pathogenesis of arterial dysfunction.
Early efforts to attribute specific cardiovascular functions to different Cx subtypes involved creation of global knockout (KO) mouse strains. However, pinpointing the precise function of these proteins has been difficult as a result of embryonic lethality in the case of the Cx43KO and Cx45KO mice, and lack of cardiovascular phenotype in the case of the Cx37KO mice. [16] [17] [18] In contrast, Cx40KO mice are profoundly hypertensive but display dysfunction of multiple cardiovascular organs, including the heart, kidney, and vasculature. [19] [20] [21] [22] The recent creation of mice with a renin-specific deletion of Cx40 has enabled the hypertensive phenotype to be attributed to ectopic localization of renin secreting cells and uncontrolled renin secretion. 23 In support of this conclusion, mice with an endothelial-specific deletion of Cx40 are normotensive. 23 Nevertheless, endothelial deletion of Cx40 does impair agonist-induced conducted vasodilation, a process which links tissue blood flow to metabolic activity, 24 although effects on other vascular responses, such as the myogenic response, have not been tested. However, deletion of Cx40 in the global and promoter-specific mice is accompanied by coordinate downregulation of Cx37 in the endothelium, making attribution of vascular defects specifically to Cx40 difficult. 25, 26 We have therefore developed a new strategy to investigate the role of endothelial Cx40 in vascular function. Rather than deleting Cx40, we have created a transgenic mouse strain that expresses a mutant form of Cx40, specifically in the endothelium, in addition to the endogenously expressed Cx40. The single-point site targeted for mutation lies in the center of a short 6 amino acid sequence previously shown to be critical for gap junction function. [27] [28] [29] This strategy was chosen because it would allow us to also test the potential of a singlepoint Cx40 mutation, as it occurs in the human population, 30, 31 to alter vascular function. We hypothesized that Cx37 expression would not be altered because Cx40 would not be absent from the cell membrane. Using this model, we aimed to determine whether impairment of endothelial Cx40 affects vascular function, by studying the myogenic response and arterial stiffening, vascular characteristics which are altered in aging and hypertension. 32, 33 
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Mutation at Position 202 Impairs Electric Conduction Through Hemichannels but Not Gap Junctions
The ability of the mutated form of Cx40, Cx40T202S to form functional hemichannels and gap junctions was tested in isolated and paired Xenopus oocytes, respectively.
Isolated oocytes were divided into 2 groups based on the amplitude of their endogenous divalent-free Cx38 hemichannel currents. In oocytes with small endogenous currents, expression of wild-type Cx40 (wtCx40) produced a significant increase in hemichannel current ( Figure 1A ; P<0.05), whereas the Cx40T202S mutant induced no increase in hemichannel currents, whether injected alone or with wtCx40. In oocytes with large endogenous currents, wtCx40 had no further effect ( Figure 1B ; P>0.05). In contrast, expression of the Cx40T202S mutant significantly reduced the endogenous Cx38 current (P<0.05), but this could be restored by injection with wtCx40 ( Figure 1B) . Thus, the Cx40T202S mutant does not form functional hemichannels and shows a dominant-negative inhibition of the Xenopus orthologue of Cx37, but not of wtCx40 hemichannels.
Paired oocytes, in which endogenous Cx currents were suppressed with antisense oligonucleotides against Cx38, were electrically coupled to a similar extent after injection of both cells with either wtCx40 or Cx40T202S ( Figure  1C ). Similar electric coupling was obtained when ooctyes expressing Cx40T202S were paired with those expressing wtCx40, or when oocytes expressing wtCx40 were paired with oocytes expressing both wtCx40 and Cx40T202S. Electrical coupling was also observed when Cx40T202S, with or without coexpression of wtCx37, was paired with wtCx37 ( Figure 1D ). These results surprisingly show that gap junction formation, as measured by electric coupling, is normal for the Cx40T202S mutant in homotypic, heterotypic (with wtCx40 or wtCx37), and even heteromeric configurations.
Mutation at Position 202 Impairs Chemical Conduction Through Gap Junctions
To examine the impact of the T202S mutation on junctional coupling in endothelial cells, we expressed wtCx40 or Cx40T202S in mouse coronary endothelial cells (MCECs) and used the ester (calcein-AM) transfer (or parachute) assay. Both Cx40 transgenes expressed well, whereas there was no expression of endogenous Cx40 protein ( Figure  1E ). MCEC lines expressed Cx43 and Cx45 and low levels of Cx37. Addition of labeled wtCx40-expressing cells to monolayers of untransfected MCEC resulted in a significant (P<0.05) increase in dye transfer compared with that achieved with MCEC expressing empty vector ( Figure 1F ). MCEC expressing Cx40T202S did not exhibit the same increase in dye coupling ( Figure 1F ). The dye transfer and electric coupling data together suggest that the Cx40T202S mutant fails to form functional hemichannels but forms gap junctional channels that are permeable to electric, but not chemical, signals.
Transgenic Mice Express Wild-Type or Mutant Cx40 Selectively in the Endothelium
Transgenic mice were created to coexpress wtCx40 (Cx40Tg) or Cx40T202S (Cx40T202STg) constructs with the reporter enhanced green fluorescent protein (EGFP), under control of the endothelial-specific promoter Tie2 because neither protein would be distinguishable from endogenously expressed Cx40, using antibodies made against intracellular epitopes. 7 mRNA for EGFP was expressed in the arteries of both transgenic strains (Figure 2A , top). Importantly, mRNA for the Cx40 or Cx40T202S transgenes was only expressed in the appropriate arterial samples, using primers which distinguished between the 2 Cx40 transgenes and endogenous Cx40 (Figure 2A , middle and bottom).
Protein expression of wtCx40 and Cx40T202S transgenes was verified by Western blotting of arterial homogenates and detection of EGFP ( Figure 2B ). Tissue specificity of transgene expression was confirmed by immunohistochemical detection of EGFP selectively in the endothelium of cremaster arterioles, mesenteric arteries ( Figure 2C ), basilar and renal vessels (data not shown).
Body Weight, Blood Pressure, and Heart Rate Are Not Altered in Cx40T202STg Mice
There were no significant differences found among the average body weights of wild-type, transgenic, and Cx40KO mice ( Table 1 ). Blood pressure and heart rate of Cx40T202STg or Cx40Tg mice were also not significantly different from values recorded in wild-type mice ( Table 1 ). In contrast, Cx40KO mice were hypertensive, as reported previously. 19 
Expression of the Cx40T202S Transgene Does Not Eliminate Cx37 Expression
To determine the effect of the Cx40T202S transgene or the overexpression of Cx40 on other endothelial Cxs, mesenteric arteries from wild-type, Cx40T202STg, and Cx40Tg mice were probed using antibodies to Cx37, Cx40, and Cx43. Staining for Cx37 and Cx40 was found delineating endothelial cells in arteries from wild-type and transgenic mice, whereas Cx43 was not detected ( Figure 3A ). Quantification revealed a significant decrease in Cx37 expression in both transgenic strains, but no significant change to Cx40 ( Figure 3B and 3C). Cx40 and Cx37 were absent from mesenteric arteries of Cx40KO mice ( Figure 3A ).
Endothelial Cx40T202S Expression Enhances Myogenic Activation and Impairs EDH in Mesenteric Resistance Arteries
We assessed the effect of transgene expression on active diameter (in the presence of CaCl 2 ) and the myogenic response of mesenteric resistance arteries. Mice used for these studies and for calculations of arterial stiffness were not significantly different in age (wild-type: 10.6±0.4 weeks; Cx40T202STg: 11.2±0.6 weeks; Cx40Tg: 10.1±0.5 weeks).
Active diameter of Cx40T202STg arteries was significantly less than wild-type (30-50 mm Hg) and Cx40Tg arteries (40-90 mm Hg; Figure 4A ). In contrast, arteries of Cx40KO mice were significantly more relaxed than wild-type (50-90 mm Hg) and Cx40Tg (70-90 mm Hg; Figure 4A ).
The myogenic response was activated at significantly lower pressures in Cx40T202STg arteries compared with wild-type, whereas activation of arteries from Cx40Tg mice occurred at significantly higher pressures ( Figure  4B ; Table 2 ). There was no significant difference between the maximum tone reached by arteries from wild-type and transgenic strains ( Figure 4B ; Table 2 ). Arteries from Cx40KO mice were less sensitive to pressure, and maximum tone achieved was significantly lower than wild-type ( Figure  4B ; Table 2 ). Because gap junctions have been implicated in vasodilation attributable to EDH, 29 we investigated the role of dilatory pathways in modulating myogenic responses. Elimination of nitric oxide, using the nitric oxide synthase inhibitor, L-NAME, in combination with the nitric oxide scavenger, hydroxocobalamin, increased the sensitivity of the myogenic response in all 4 genotypes and the maximum tone in wild-type and Cx40T202STg mice ( Figure  4C -4F, Table 2 ). Because hydroxocobalamin can quench hydrogen sulfide, possible effects of this new signaling molecule could not be identified. Subsequent addition of TRAM-34 (IK Ca antagonist) and UCL1684 (SK Ca antagonist) to block EDH increased the myogenic sensitivity to pressure in wild-type and Cx40Tg mice but was without effect in Cx40T202STg or Cx40KO mice ( Figure 4C -4F, Table 2 ).
Endothelial Cx40T202S Expression Increases Stiffness of Mesenteric Resistance Arteries
Given the enhanced myogenic activation of arteries from Cx40T202STg mice, we determined whether lifetime expression of Cx40T202S could cause mechanical changes in these vessels. Analysis of the passive diameter-pressure relationship showed no significant difference between arteries from wild-type and transgenic mice; however, passive lumen diameter of Cx40T202STg arteries was significantly narrower than Cx40Tg arteries at pressures >40 mm Hg ( Figure 5A ). This Mesenteric arteries from wild-type (WT), Cx40T202STg, Cx40Tg, and Cx40KO mice respond differently to intraluminal pressure. A, Cx40T202STg (n=13) arteries were significantly more constricted than those of WT (n=13) and Cx40Tg (n=13) mice, whereas Cx40KO (n=11) arteries were significantly more dilated. B, The myogenic response was activated at lower pressures in Cx40T202STg arteries and at higher pressures in Cx40Tg arteries, compared with WT. Maximum constriction of Cx40KO arteries was smaller than in the other genotypes. C, In WT arteries (n=7), blockade of NO with L-NAME and hydroxocobalamin, and endothelium-derived hyperpolarization (EDH) with TRAM-34 (IK Ca ) and UCL1684 (SK Ca ) shifted activation to lower pressures. D, In Cx40T202STg (n=6) arteries, blockade of NO shifted activation of the myogenic response to lower pressures, but EDH had no effect. E, Sensitivity of Cx40Tg (n=6) arteries was similar to that of WT arteries. F, Sensitivity of Cx40KO (n=6) arteries was similar to that of Cx40T202STg arteries. *P<0.05 compared with WT, †P<0.05 compared with Cx40Tg.
narrowing was not attributable to eutrophic or hypertrophic remodeling because media/lumen ratios were equal for all genotypes ( Figure 5B ). However, the strain-pressure relationship was significantly reduced in Cx40T202STg arteries compared with wild-type and Cx40Tg, suggesting reduced distensiblity ( Figure 5C ). Subsequent analysis of the stress-pressure relationship showed no difference between the genotypes; however, analysis of the stress-strain relationship revealed a leftward shift in Cx40T202STg arteries ( Figure 5D and 5E). When exponential curves were fitted to the stressstrain data from each artery, the mean β-coefficient value was significantly higher in Cx40T202STg arteries compared with wild-type and Cx40Tg arteries, indicating an increase in the wall component stiffness ( Figure 5F ).
Responses to Contracting and Dilating Agents
Arteries from Cx40Tg mice were significantly more sensitive to the vasodilator, calcitonin gene related peptide (CGRP), than wild-type or Cx40T202STg arteries ( Figure II and Table I in the online-only Data Supplement). Although maximal relaxation to CGRP did not vary between the genotypes, the increased vascular tone of Cx40T202STg arteries resulted in significant residual tone in the presence of supramaximal concentrations of CGRP (Table I in 
the online-only Data Supplement).
There was no difference among the genotypes in the sensitivity to phenylephrine (PE) or the total vascular tone achieved at 70 mm Hg ( Figure III in the online-only Data Supplement). However, the maximum constriction to PE was significantly greater in Cx40Tg arteries than in Cx40T202STg and wildtype arteries ( Table I in 
Total vascular tone achieved at 70 mm Hg in the presence of αβ-methylene-ATP was also not significantly different among the genotypes; however, the magnitude of the constriction was significantly greater in Cx40Tg than in Cx40T202STg arteries, as was the rebound vasodilation ( Figure IV 
Discussion
Our data show for the first time that perturbations in endothelial Cx40 function cause significant effects on the myogenic response to intraluminal pressure and on arterial stiffness; vascular characteristics which are altered in cardiovascular disease. Consistent with these data, mice overexpressing Cx40 in the endothelium show myogenic responses, which are less sensitive to intraluminal pressure, and show no sign of arterial stiffening. These data have been obtained in mice in which we have introduced a mutant form of Cx40 into the endogenous Cx40 population. We have therefore also shown that a singlepoint mutation in endothelial Cx40 can produce significant alterations in cardiovascular function; a causal association previously suggested for only human Cx40 polymorphisms. 30 To study endothelial Cx40, our goal was to avoid the coordinate downregulation of endothelial Cx37 seen after the absence of Cx40 in Cx40KO mice (present study). 25, 26 In line with this, our immunohistochemical studies showed that Cx37 was not lost from the endothelial cell membrane of Cx40T202STg mice, although expression was reduced to 60%. This interesting result may suggest that coordinate regulation of Cx37 and Cx40 results from commonality in their interaction partners in the multiprotein nexus, which is increasingly seen to control Cx trafficking, localization, and function. 34 In support of this, a similar decrease in Cx37 expression was also found in the arteries of our Tg mice overexpressing Cx40. However, in spite of this commonality in effects on Cx37 expression, the effects of the wild-type and mutant Cx40T202S transgenes on arterial function and stiffness were always opposite. Therefore, we conclude that the arterial dysfunction, which we have observed in Cx40T202STg mice, can be attributed to effects on endothelial Cx40, without contribution from Cx37.
To understand how the Cx40T202S mutation affected arterial function, we conducted in vitro experiments in oocytes and endothelial cells to investigate both hemichannel and gap junctional function. Although the Cx40T202S mutant did not form functional hemichannels, experiments in paired oocytes demonstrated that the mutant was expressed in the cell membrane and could form electrically competent gap junctions with other mutant Cx40T202S molecules, as well as with wtCx40 or wtCx37 hemichannels. However, the Cx40T202S mutation did not act as a dominant negative to downregulate electric function of wtCx40 gap junctions or hemichannels, although such an effect was found on hemichannels formed with Cx38, the amphibian orthologue of Cx37. Nevertheless, the passage of larger molecules through mutant Cx40T202S gap junctions was impaired in endothelial cells. From these data, we conclude that the Cx40T202S mutant impairs the function of endothelial hemichannels, as well as chemical, but not electric coupling between endothelial cells, or through myoendothelial gap junctions.
In cardiovascular diseases and aging, the contractile properties of resistance arteries have been shown to be altered. 32, 33, 35 For this reason we chose to examine the myogenic constriction of third order mesenteric arteries in our transgenic mouse strains. Our data demonstrate that selective impairment of endothelial Cx40 enhances activation of the myogenic response, whereas overexpression of Cx40 reduces sensitivity; both without effect on the maximal response. In contrast, arteries from Cx40KO mice exhibited both reduced sensitivity to pressure and lower maximum tone. As different models of cardiovascular disease demonstrate both increased and decreased contractility of arteries, measured using pressure myography, 32, 35 we suspect that the decreased contractility of Cx40KO arteries is likely attributable to 2 exogenous, but related, factors. First, these arteries encounter extremely high pressures in vivo, 19 an effect that has been shown to cause a shift in myogenic activation to higher pressures. 32 Second, Cx40KO arteries in vivo are chronically exposed to the potent vasoconstrictor, angiotensin II. A lack of this stimulus in the in vitro pressure myograph may be expected to reduce contractility.
Because the site of impairment in Cx40T202STg mice is endothelial, it was important that we assess whether altered endothelial dilator capacity was responsible for the enhanced myogenic activation. In mesenteric arteries of wild-type mice, we found that both endothelial nitric oxide production and EDH were significant modulators of the myogenic response in the absence of any agonist or flow-induced activation. This in itself was a surprising finding, suggesting that intraluminal pressure per se could stimulate the release of these vasodilatory factors. Consistent with the data obtained in wild-type arteries, nitric oxide and EDH were also important for desensitizing the myogenic response in pressurized arteries from our Cx40Tg mice, which overexpress endothelial Cx40. However, blockade of EDH had no effect on arteries from Cx40T202STg or Cx40KO mice, indicating that perturbation in endothelial Cx40 function completely abrogates this myogenically induced EDH activity.
Cx40 has been strongly implicated in the agonist-induced activation of EDH in small mesenteric arteries because endothelial loading of antibodies to Cx40, but not to Cx37 or Cx43, reduced EDH and immunoelectronmicroscopylocalized Cx40 to myoendothelial gap junctions. 36 Given that our Cx40T202S mutant is capable of forming electrically competent gap junctions, it seems unlikely that the myogenically induced activation of EDH in response to increased intraluminal pressure, found in this study, could be initiated in the endothelium. In contrast, because the Cx40T202S mutation reduces chemical coupling through gap junctions, our results provide compelling evidence that EDH is activated by substances moving from the smooth muscle to the endothelium through myoendothelial gap junctions, after smooth muscle constriction ( Figure 6 ). Such movement of a chemical mediator, such as calcium or IP 3 , through myoendothelial gap junctions, has been suggested previously to be responsible for the termination of agonistinduced vasoconstriction, attributable to activation of nitric oxide or EDH. [37] [38] [39] [40] [41] Our data show that this chemical movement is mediated by gap junctions comprising endothelial Cx40, and that the response can be activated physiologically by raising intraluminal pressure. The lack of effect on nitric oxide in our Cx40T202STg mice suggests that basal release of nitric oxide in pressurized small mesenteric arteries does not involve such a mechanism.
In suggesting this role, we acknowledge that endothelial Cx40 hemichannels could form myoendothelial gap junctions with any of the 3 potentially expressed smooth muscle Cxs (Cx37, Cx43, Cx45), [42] [43] [44] and that the properties of these Cxs may differentially affect the chemical permeability of the endothelial connexons composed of Cx40T202S. 7 Although our findings in Cx40T202STg mice are consistent with impaired myoendothelial feedback, they do not allow us to specify which of the potential heterotypic gap junctions may be involved.
The observation of enhanced constriction after lifelong alteration to endothelial Cx function in arteries of our Cx40T202STg mice led us to investigate whether this stress could lead to changes in artery structure, as it occurs in hypertension and aging. Although pressure-diameter relationships of mesenteric arteries were not significantly different between wild-type and Cx40 overexpressing transgenic strains, Cx40T202S mutant arteries exhibited increased contractility, reduced distensibility, and increased component stiffness of the vascular wall. We further show that increased contractility at physiological intraluminal pressures in these vessels leads to reduction in the maximal vasodilation evoked by endogenous vasodilators, without change in sensitivity. Vasodilation after vasoconstriction evoked by the neural agonist, αβ-methylene-ATP, was also attenuated. Our data therefore provide new evidence that endothelial dysfunction, resulting from impairment to endothelial hemichannels, or chemical coupling via endothelial gap junctions can result in arterial stiffening and attenuated responses to endogenous vasodilators.
Although polymorphisms in the human Cx40 promoter region have been shown to reduce Cx40 mRNA levels in atria and correlate with the incidence of atrial fibrillation, 45, 46 only 1 study has investigated a possible relationship with coronary artery disease; however, no association was found. 47 To our knowledge, our study is the first to examine whether polymorphisms in the coding region of Cx40 associate with dysfunction of the arterial wall. Interestingly, many studies have reported associations between the polymorphism 1019C>T in the coding region of Cx37 and both atherosclerosis and coronary artery disease. [48] [49] [50] Together, these data suggest that investigation of associations between polymorphisms in the coding region of human Cx40 and vascular disease may be a promising avenue for future studies.
In spite of significant changes to artery structure and function, no alteration in blood pressure or heart rate was found in Cx40T202STg mice, compared with wild-type mice or mice overexpressing Cx40. This lack of effect was not unexpected because mice with an endothelial-specific deletion of Cx40 are also normotensive, in contrast to those with a renal specific deletion of Cx40 that are hypertensive. 23 The results of the present study demonstrate that chemical coupling by endothelial Cx40 is necessary for basal EDH, an effect recently shown to depend on myoendothelial feedback. [38] [39] [40] The chronic impairment of this vasodilatory function in Cx40T202STg mice causes enhanced myogenic activation and likely contributes to the increased stiffness found in mesenteric resistance arteries, although impairment to endothelial hemichannels, where Cx37 is expressed, could also contribute to the latter phenomenon. To our knowledge, this is the first report of a causal link between impairment of endothelial Cx40, as has been seen in hypertension and aging, and the arterial stiffening and dysfunction observed in these conditions. Importantly, this vascular dysfunction has been induced by a single-point mutation in an extracellular loop of Cx40, existing as a polymorphism in an endogenous endothelial population of Cx40 molecules. Cx37 Cx37 X Figure 6 . Proposed mechanism for the impairment of basal endothelium-derived hyperpolarization activated through the myogenic response. A, Endothelial cells express connexin proteins that allow the formation of gap junctions with smooth muscle cells and other endothelial cells. Gap junctions on myoendothelial projections allow hyperpolarizing current generated by endothelial cells to pass into smooth muscle cells to cause relaxation. Hyperpolarizing current can be initiated in endothelial cells via the passage of second messenger molecules generated during constriction of smooth muscle cells in response to increase in intraluminal pressure. B, Expression of Cx40T202S in endothelial cells blocks the passage of second messengers from smooth muscle cells, thereby preventing activation of endothelial hyperpolarization.
